Benefit of stopping finite nucleos(t)ide analogues therapy in chronic hepatitis B patients | Gut

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

PostScript

PostScript

Benefit of stopping finite nucleos(t)ide analogues therapy in chronic hepatitis B patients

Online download statistics by month:

Online download statistics by month: November 2019 to March 2024

	Abstract	Full	Pdf
Nov 2019	147	6	8
Dec 2019	727	63	39
Jan 2020	347	18	12
Feb 2020	143	10	4
Mar 2020	63	7	2
Apr 2020	57	6	3
May 2020	35	2	1
Jun 2020	56	1	1
Jul 2020	44	5	3
Aug 2020	90	10	8
Sep 2020	347	37	29
Oct 2020	135	18	13
Nov 2020	95	16	9
Dec 2020	93	3	4
Jan 2021	130	8	8
Feb 2021	70	7	5
Mar 2021	61	4	3
Apr 2021	136	4	5
May 2021	49	4	5
Jun 2021	8	4	6
Jul 2021	5	4	3
Aug 2021	7	5	2
Sep 2021	9	5	4
Oct 2021	41	5	1
Nov 2021	56	7	2
Dec 2021	33	1	1
Jan 2022	67	5	4
Feb 2022	25	4	3
Mar 2022	62	6	3
Apr 2022	53	2	1
May 2022	51	4	1
Jun 2022	61	5	1
Jul 2022	80	4	2
Aug 2022	45	2	1
Sep 2022	52	2	0
Oct 2022	44	1	1
Nov 2022	23	0	0
Dec 2022	27	1	1
Jan 2023	59	1	1
Feb 2023	89	0	1
Mar 2023	19	3	1
Apr 2023	12	0	0
May 2023	15	1	0
Jun 2023	14	0	0
Jul 2023	26	1	0
Aug 2023	17	1	0
Sep 2023	47	0	2
Oct 2023	19	0	0
Nov 2023	29	3	1
Dec 2023	12	0	0
Jan 2024	13	0	0
Feb 2024	12	0	0
Mar 2024	11	2	1
Total	3968	308	206